Quest Diagnostics ROE 2006-2018 | DGX

Current and historical return on equity (ROE) values for Quest Diagnostics (DGX) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.023B $7.709B
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Stock Name Country Market Cap PE Ratio
DaVita (DVA) United States $12.524B 19.40
Encompass Health (EHC) United States $6.848B 23.10
Envision Healthcare (EVHC) United States $5.416B 16.81
Chemed (CHE) United States $5.165B 33.20
Amedisys (AMED) United States $3.202B 37.15
LHC Group (LHCG) United States $2.851B 34.45
U.S Physical Therapy (USPH) United States $1.252B 46.63
RadNet (RDNT) United States $0.712B 46.09
Addus HomeCare (ADUS) United States $0.699B 39.87
American Renal Associates Holdings (ARA) United States $0.500B 24.08
BioScrip (BIOS) United States $0.384B 0.00
AAC Holdings (AAC) United States $0.247B 16.46
Quorum Health (QHC) United States $0.133B 0.00
Psychemedics (PMD) United States $0.110B 23.31
Catasys (CATS) United States $0.108B 0.00
Helios And Matheson Analytics Inc (HMNY) United States $0.040B 0.00
Daxor (DXR) United States $0.023B 0.00